Drug targeting of heme proteins ion Mycobacterium tuberculosis

被引:17
|
作者
McLean, Kirsty J. [1 ]
Munro, Andrew W. [1 ]
机构
[1] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, 131 Princess St, Manchester M1 7DN, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
CHOLESTEROL CATABOLIC PATHWAY; CATALASE-PEROXIDASE GENE; CELL-WALL; TRUNCATED HEMOGLOBIN; TRANSCRIPTIONAL REGULATION; ISONIAZID RESISTANCE; CYP121; INHIBITORS; MEMBRANE-PROTEINS; IRON-METABOLISM; KATG EXPRESSION;
D O I
10.1016/j.drudis.2016.11.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
TB, caused by the human pathogen Mycobacterium tuberculosis (Mtb), causes more deaths than any other infectious disease. Iron is crucial for Mtb to infect the host and to sustain infection, with Mtb encoding large numbers of iron-binding proteins. Many of these are hemoproteins with key roles, including defense against oxidative stress, cellular signaling and regulation, host cholesterol metabolism, and respiratory processes. Various heme enzymes in Mtb are validated drug targets and/or products of genes essential for bacterial viability or survival in the host. Here, we review the structure, function, and druggability of key Mtb heme enzymes and strategies used for their inhibition.
引用
收藏
页码:566 / 575
页数:10
相关论文
共 50 条
  • [1] PPE Surface Proteins Are Required for Heme Utilization by Mycobacterium tuberculosis
    Mitra, Avishek
    Speer, Alexander
    Lin, Kan
    Ehrt, Sabine
    Niederweis, Michael
    MBIO, 2017, 8 (01):
  • [2] Heme degradation in Mycobacterium tuberculosis
    Ikeda-Saito, Masao
    Matsui, Toshitaka
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 120 : S11 - S11
  • [3] Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery
    Singh, Vijai
    Somvanshi, Pallavi
    LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (07) : 487 - 493
  • [4] Heme and hemoglobin utilization by Mycobacterium tuberculosis
    Mitra, Avishek
    Ko, Ying-Hui
    Cingolani, Gino
    Niederweis, Michael
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [5] Heme and hemoglobin utilization by Mycobacterium tuberculosis
    Avishek Mitra
    Ying-Hui Ko
    Gino Cingolani
    Michael Niederweis
    Nature Communications, 10
  • [6] Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis
    Xu, Xinyue
    Dong, Baoyu
    Peng, Lijun
    Gao, Chao
    He, Zhiqun
    Wang, Chuan
    Zeng, Jumei
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [7] NMR for lead identification and optimization: Drug discovery targeting Mycobacterium tuberculosis
    Kapilashrami, Kanishk
    Machutta, Carl A.
    Bommineni, Gopal Reddy
    Picart, Francis
    Tonge, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [8] Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis
    Mishra, Richa
    Kohli, Sakshi
    Malhotra, Nitish
    Bandyopadhyay, Parijat
    Mehta, Mansi
    Munshi, MohamedHusen
    Adiga, Vasista
    Ahuja, Vijay Kamal
    Shandil, Radha K.
    Rajmani, Raju S.
    Seshasayee, Aswin Sai Narain
    Singh, Amit
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (518)
  • [9] Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target
    Owens, Cedric P.
    Chim, Nicholas
    Goulding, Celia W.
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (12) : 1391 - 1403
  • [10] HemZ is essential for heme biosynthesis in Mycobacterium tuberculosis
    Parish, T
    Schaeffer, M
    Roberts, G
    Duncan, K
    TUBERCULOSIS, 2005, 85 (03) : 197 - 204